Condition: Autoimmune Diseases · Systemic Lupus Erthematosus · Multi-Drug Resistant Nephrotic Syndrome · Sponsor: The Children's Hospital of Zhejiang University School of Medicine
this is an investigator-initiated trial aimed at evaluating the efficacy and safety of anti-CD19/BCMA CAR-NK Cells in Patients With B cell mediated autoimmune disease.
This description comes directly from the study's public registry record.
Jianhua Mao, PhD · 13516819071 · maojh88@zju.edu.cn
Qiuyu Li, MD · 17794588355 · liqiuyu1992@zju.edu.cn
Always discuss trial participation with your own doctor first.
| Children's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310000 | Hangzhou, Zhejiang, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06792799